Obalon Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.67 |
Market Cap |
$21.05 M |
Shares Outstanding |
34.79 M |
Public Float |
10.5 M |
Address |
5421 Avenida Encinas Carlsbad California 92008 United States |
Employees | - |
Website | http://www.obalon.com |
Updated | 07/08/2019 |
Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes medical balloon technology for weight loss therapy which consists of a capsule containing a balloon that is swallowed and then remotely inflated. The company was founded in January 2008 and is headquartered in San Diego, CA. |